Figure 2From: Identification of losses to follow-up in a community-based antiretroviral therapy clinic in South Africa using a computerized pharmacy tracking system Long-term outcomes (one year after the cross-sectional survey) of patients who either had no pharmacy delay (n = 1988) or who delayed collecting antiretroviral therapy (ART) for ≥6, ≥12, ≥18 or ≥24 weeks. For each group, the proportions of patients with each outcome are shown.Back to article page